Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 21921726)

1.

Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.

Stuart GS, Moses A, Corbett A, Phiri G, Kumwenda W, Mkandawire N, Chintedze J, Malunga G, Hosseinipour M, Cohen MS, Stanczyk FZ, Kashuba AD.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e40-3. doi: 10.1097/QAI.0b013e31822b8bf8. No abstract available.

2.

Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.

Hosseinipour MC, Corbett AH, Kanyama C, Mshali I, Phakati S, Rezk NL, van der Horst C, Kashuba AD.

AIDS. 2007 Jan 2;21(1):59-64.

PMID:
17148968
3.
4.

Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.

Westhoff CL, Torgal AH, Mayeda ER, Pike MC, Stanczyk FZ.

Contraception. 2010 Jun;81(6):474-80. doi: 10.1016/j.contraception.2010.01.016. Epub 2010 Feb 20.

5.

The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.

Sevinsky H, Eley T, Persson A, Garner D, Yones C, Nettles R, Krantz K, Bertz R, Zhang J.

Antivir Ther. 2011;16(2):149-56. doi: 10.3851/IMP1725.

PMID:
21447863
6.
7.

Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women.

Mildvan D, Yarrish R, Marshak A, Hutman HW, McDonough M, Lamson M, Robinson P.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):471-7.

PMID:
11981363
8.

Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogen.

DiLiberti CE, O'Leary CM, Hendy CH, Waters DH, Margolis MB.

Contraception. 2011 Jan;83(1):55-61. doi: 10.1016/j.contraception.2010.06.015. Epub 2010 Aug 7.

PMID:
21134504
9.

Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children.

Corbett AH, Hosseinipour MC, Nyirenda J, Kanyama C, Rezk NL, Mkupani P, Sichali D, Tien H, Kashuba AD, Mwansambo C, Weigel R, Kazembe P.

Antivir Ther. 2010;15(1):83-90. doi: 10.3851/IMP1488.

10.

Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults.

Byakika-Tusiime J, Chinn LW, Oyugi JH, Obua C, Bangsberg DR, Kroetz DL.

PLoS One. 2008;3(12):e3981. doi: 10.1371/journal.pone.0003981. Epub 2008 Dec 19.

12.

Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.

Fillekes Q, Mulenga V, Kabamba D, Kankasa C, Thomason MJ, Cook A, Ferrier A, Chintu C, Walker AS, Gibb DM, Burger DM.

AIDS. 2012 Sep 10;26(14):1795-800. doi: 10.1097/QAD.0b013e32835705fd.

PMID:
22739394
13.

Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.

Edelman AB, Cherala G, Munar MY, Dubois B, McInnis M, Stanczyk FZ, Jensen JT.

Contraception. 2013 Feb;87(2):220-6. doi: 10.1016/j.contraception.2012.10.008. Epub 2012 Nov 12.

14.

Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive.

Braun M, Elshoff JP, Andreas JO, M├╝ller LI, Horstmann R.

Br J Clin Pharmacol. 2009 Sep;68(3):386-94. doi: 10.1111/j.1365-2125.2009.03468.x.

15.

Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets.

Pollock L, Else L, Poerksen G, Molyneux E, Moons P, Walker S, Fraser W, Back D, Khoo S.

J Antimicrob Chemother. 2009 Dec;64(6):1251-9. doi: 10.1093/jac/dkp358. Epub 2009 Oct 6.

16.

Effect of empagliflozin on the steady-state pharmacokinetics of ethinylestradiol and levonorgestrel in healthy female volunteers.

Macha S, Mattheus M, Pinnetti S, Woerle HJ, Broedl UC.

Clin Drug Investig. 2013 May;33(5):351-7. doi: 10.1007/s40261-013-0068-y.

PMID:
23512637
17.

Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection.

Fletcher CV, Yogev R, Nachman SA, Wiznia A, Pelton S, McIntosh K, Stanley K.

Pharmacotherapy. 2004 Apr;24(4):453-9.

PMID:
15098798
18.
19.

BMI, pharmacokinetics, and OCP failure.

Cherala G, Edelman A.

Contraception. 2010 Dec;82(6):582; author reply 581-2. doi: 10.1016/j.contraception.2010.05.002. Epub 2010 Jun 18. No abstract available.

PMID:
21074028
20.

The lack of interaction between temafloxacin and combined oral contraceptive steroids.

Back DJ, Tjia J, Martin C, Millar E, Mant T, Morrison P, Orme M.

Contraception. 1991 Apr;43(4):317-23.

PMID:
1906791
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk